These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7053863)

  • 1. Effect of estrogen and progesterone on cellular replication of human breast tumors.
    Dao TL; Sinha DK; Nemoto T; Patel J
    Cancer Res; 1982 Jan; 42(1):359-62. PubMed ID: 7053863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer.
    Conte PF; Fraschini G; Alama A; Nicolin A; Corsaro E; Canavese G; Rosso R; Drewinko B
    Cancer Res; 1985 Nov; 45(11 Pt 2):5926-30. PubMed ID: 4053064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers--a Southwest Oncology Group study.
    Fabian CJ; Kimler BF; McKittrick R; Park CH; Lin F; Krishnan L; Jewell WR; Osborne CK; Martino S; Hutchins LF
    Cancer Res; 1994 Oct; 54(20):5357-62. PubMed ID: 7923165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of human breast cancer cell kinetics measured by flow cytometry and thymidine labeling.
    McDivitt RW; Stone KR; Craig RB; Meyer JS
    Lab Invest; 1985 Mar; 52(3):287-91. PubMed ID: 2983150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro influence of estradiol or progesterone on the thymidine labeling indices of human benign breast tumors.
    Coibion M; Kiss R; Jossa V; de Launoit Y; Van Geloven O; Malengreau A; Mattheiem W; Pasteels JL; Paridaens R
    Anticancer Res; 1989; 9(2):475-82. PubMed ID: 2751271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel hormone-responsive cell lines derived from primary human breast carcinomas: functional characterization.
    Vázquez SM; Mladovan A; Garbovesky C; Baldi A; Lüthy IA
    J Cell Physiol; 2004 Jun; 199(3):460-9. PubMed ID: 15095293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
    Mira-y-Lopez R; Ossowski L
    Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
    Harrell JC; Dye WW; Allred DC; Jedlicka P; Spoelstra NS; Sartorius CA; Horwitz KB
    Cancer Res; 2006 Sep; 66(18):9308-15. PubMed ID: 16982776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
    Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
    Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.